Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine

被引：0
作者：
Jing Jin
Feng-Peng Wang
Huailing Wei
Gengtao Liu
机构：
[1] University of Cambridge,Department of Pharmacology
[2] Sichuan University,Department of Medicinal Natural Products, West China College of Pharmacy
[3] Chinese Academy of Medical Sciences,Department of Pharmacology, Institute of Materia Medica
[4] Peking Union Medical College and Chinese Academy of Medical Sciences,Department of Pharmacology, Institute of Materia Medica
来源：
Cancer Chemotherapy and Pharmacology | 2005年 / 55卷
关键词：
Multidrug resistance; Modulator; Bromotetrandrine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：179 / 188
页数：9
相关论文
共 50 条
  • [21] Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein
    Yinxu Zhang
    Xiaomei Liu
    Teng Zuo
    Yu Liu
    Jun Hua Zhang
    Medical Oncology, 2012, 29 : 534 - 538
  • [22] Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents
    Chen, Chien-Yu
    Liu, Nai-Yu
    Lin, Hui-Chang
    Lee, Chih-Yu
    Hung, Chin-Chuan
    Chang, Chih-Shiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 118 : 219 - 229
  • [23] Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein
    Zhang, Yinxu
    Liu, Xiaomei
    Zuo, Teng
    Liu, Yu
    Zhang, Jun Hua
    MEDICAL ONCOLOGY, 2012, 29 (02) : 534 - 538
  • [24] P-GLYCOPROTEIN, MULTIDRUG-RESISTANCE AND TUMOR PROGRESSION
    BRADLEY, G
    LING, V
    CANCER AND METASTASIS REVIEWS, 1994, 13 (02) : 223 - 233
  • [25] Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
    Sikic, BI
    Fisher, GA
    Lum, BL
    Halsey, J
    BeketicOreskovic, L
    Chen, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) : S13 - S19
  • [26] Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
    B. I. Sikic
    George A. Fisher
    Bert L. Lum
    Joanne Halsey
    Lidija Beketic-Oreskovic
    Gang Chen
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S13 - S19
  • [27] EFFECTS OF PHOSPHORYLATION OF P-GLYCOPROTEIN ON MULTIDRUG-RESISTANCE
    GERMANN, UA
    CHAMBERS, TC
    AMBUDKAR, SV
    PASTAN, I
    GOTTESMAN, MM
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1995, 27 (01) : 53 - 61
  • [28] P-glycoprotein, multidrug resistance and protein kinase C
    Fine, RL
    Chambers, TC
    Sachs, CW
    STEM CELLS, 1996, 14 (01) : 47 - 55
  • [29] Non P-glycoprotein novel proteins involved in human cancer multidrug resistance
    Baggetto, LG
    BULLETIN DU CANCER, 1997, 84 (04) : 385 - 390
  • [30] INTERACTION OF TAMOXIFEN WITH THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN
    CALLAGHAN, R
    HIGGINS, CF
    BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 294 - 299
12345